article thumbnail

Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis

IDStewardship

In 2014, the US FDA approved this regimen, and it features in the latest WHO guidelines for LTBI treatment. The rifapentine group had higher treatment completion rates (82.1% versus 69%) than the isoniazid group, mirroring findings from U.S. TB Control Programs 21. Acta Ophthalmol. 2015;93:402–10. doi: 10.1111/aos.12515. Chan RY, Kwok AK.

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

This commitment, combined with her vision and leadership, led to the launch of PolicyMap in 2008. Image Maggie McCullough 12 June, 2025 pharmacy deserts Bookmark this Oncology ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bl.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Radical Transparency or Radical Redundancy? FDA Publishes 200+ Complete Response Letters, Most of Which Are Already Public

The FDA Law Blog

Butler — In a move FDA is calling “radical transparency,” the Agency announced on July 10, 2025 that it has published 200+ Complete Response Letters (CRLs) issued in response to marketing applications for drugs and biologics on its openFDA database. By Sarah Wicks & Michelle L.

FDA 52
article thumbnail

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Pharmacy Times

Eligible patients include adults (≥ 18 years) diagnosed with CML receiving imatinib as first-line therapy for more than 1 month between 2008 and 2023. Materials and Methods This retrospective observational study utilized the Carolina Data Warehouse for Health electronic health record (EHR) database.

Dosage 65
article thumbnail

Wildfires Have Significant Impacts on Respiratory Health

Drug Topics

million Kaiser Permanente Southern California members from 2008 to 2019. These findings are from a 2024 study conducted by researchers at the University of Washington in Seattle, who followed more than 1.2

article thumbnail

Uruguay progresses towards developing its first regulatory agency

Pharmaceutical Technology

Since 2008, the Association of Chemistry and Pharmacy of Uruguay has played an active role in promoting a National Health Surveillance Agency, and in 2020 the government attempted to launch a similar agency but it ultimately failed.

article thumbnail

Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing

European Pharmaceutical Review

To give examples, such a work package focuses on the identification of regulations (ICH Q2 R2, 3 Q8-Q14, 4-10 FDA PAT guidance, 11 EMA Annex 15 12 ), some of which may be mainly guidance documents with recommendations and flexibility when it comes to PAT. International Council for Harmonisation (ICH), 2008. Q9 Quality Risk Management.